China Says Berry Plastics Can Buy Qingdao Packaging Producer

Plans by U.S.-based Berry Plastics Group to buy a controlling interest in Chinese packaging producer Qingdao P&B have been approved by regulatory authorities in the People's Republic.  At some point in February, Berry will complete its acquisition of 75% of the Chinese company. P&B founder Peter Song, who is currently general manager will retain a majority stake and keep his position.

In future, the company, with annual revenues of $34 million, will trade as Qingdao Berry Plastics Limited, producing rigid plastic packaging and personal care products for customers in China as well as globally. P&B operates a state-of-the-art manufacturing facility using thermoform, injection, and automated assembly manufacturing processes.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.